Bacoside A
CAS: 11028-00-5
Ref. TM-T3426
1mg | 181.00 € | ||
5mg | 448.00 € | ||
10mg | 642.00 € | ||
25mg | 1,002.00 € | ||
50mg | 1,382.00 € | ||
100mg | 1,827.00 € |
Product Information
- (5R,8R,9S,10S,13R,14R,17S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-10-(hydroxymethyl)-4,4,8,14-tetramethyl-1,2,3,5,6,7,9,11,12,13,15,17-dodecahydrocyclopenta[a]phenanthren-16-one
- 3-[(O-α-<span class="text-smallcaps">L</smallcap>-Arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxydammar-24-en-16-one
- Dammar-24-en-16-one, 3-[(O-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
- Dammar-24-en-16-one, 3-[(α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-O-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro. It exerts cytoprotective efficacy by attenuation of ROS generated through oxidative stress by an increase in the concentration of antioxidant enzymes and sustain membrane integrity which leads to restoring the damage caused by tBHP. Bacoside A can able to inhibit the progression of Experimental Autoimmune Encephalomyelitis (EAE) may be by the inhibition of inflammatory cytokines and chemokine evolved during active EAE. Bacoside A also has vasorelaxation.
Chemical properties
Technical inquiry about: TM-T3426 Bacoside A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.